SPECIAL REPORT | URN | A sub-study of the landmark clinical trial evaluating the safety and efficacy of the twice-yearly injectable HIV prevention drug, Lenacapavir, has found that it provides 100 percent protection against HIV infection among pregnant and breastfeeding women using it as pre-exposure prophylaxis (PrEP). The Phase 3 …
Read More »Experts urge caution over HIV prevention injection
Kampala, Uganda | URN | Experts have urged those who already received their first injection of the twice-yearly HIV preventing drug Lenacapavir to consider using combination prevention options, warning that the game changer injection is not a vaccine. The initial recipients of the drug that has since had a lot …
Read More »Scientists study yearly HIV prevention injection possibility
Kampala, Uganda | URN | Scientists are exploring the possibility of having the popular HIV prevention injection Lenacapavir in a formulation dispensed once a year. The drug, first approved in 2025 and whose uptake is reported to be high in Uganda as a twice-yearly Pre-Exposure Prophylaxis (PrEP), according to Senior …
Read More »Men rush for AIDS prevention drug as demand exceeds supply
Kampala, Uganda | URN | The Ministry of Health revealed Friday that demand for Lenacapavir, an HIV prevention injection launched in April, currently surpasses available doses, with more men demanding the twice-yearly drug. Speaking at a meeting attended by HIV advocates, researchers and policymakers, Dr Herbert Kadama who coordinates …
Read More »HIV jab demand outstrips supply in African rollout
Uganda and Kenya are among nine African countries to have received initial doses of the HIV drug Nairobi, Kenya | AGENCIES | Demand for a twice-yearly HIV prevention injection is outpacing supply in parts of Africa, with distribution covering a fraction of estimated need and leaving behind vulnerable slum communities, according to health …
Read More »Lenacapavir HIV prep- injectable drug launched in Lira
Lira, Uganda | URN | The Ministry of Health has launched the use of Lenacapavir, a revolutionary Pre-Exposure Prophylaxis long-acting injectable drug for HIV prevention in Uganda. The National Launch, which took place at Lira Regional Referral Hospital, was presided over by Dr. Jane Ruth Aceng Ocero, the Minister of …
Read More »Govt to roll out use of lenacapavir anti-HIV injection on Friday
Kampala, Uganda | URN | The Ministry of Health will, on Friday, roll out the countrywide use of Lenacapavir injection at Lira Regional Referral Hospital. In July last year, the World Health Organization (WHO) released guidelines recommending the use of injectable lenacapvir(LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) …
Read More »Uganda receives first batch of HIV-Prevention drug Lenacapavir
Kampala, Uganda | THE INDEPENDENT | An initial consignment of 19, 200 doses of Lanacapavir, a six-monthly HIV prevention injection drug, has arrived in Uganda, marking a major milestone in the country’s HIV prevention efforts. The arrival of the consignment donated by the Global Fund follows approval of the drug for …
Read More »Cheaper HIV prevention drug coming
Drug can be used to prevent catching the virus and treat those who have it Kampala, Uganda | THE INDEPENDENT & AGENCIES | A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between producers and key HIV/AIDS prevention …
Read More »Uganda among first to benefit from breakthrough HIV prevention drug
Lenacapavir, trialed in Uganda, offers 100% protection but will it reach those who need it most? Kampala, Uganda | RONALD MUSOKE | Thanks to a landmark deal announced on July 9 by the Global Fund, Uganda is expected to be among the first countries in sub-Saharan Africa to get access to …
Read More »
The Independent Uganda: You get the Truth we Pay the Price